US Stock MarketDetailed Quotes

DWTX Dogwood Therapeutics

Watchlist
  • 5.936
  • -0.154-2.53%
Trading Mar 18 10:00 ET
7.91MMarket Cap-0.94P/E (TTM)

Dogwood Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dogwood Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--

Unlock Free Earnings Estimates

Dogwood Therapeutics Earnings Reports

  • Dogwood Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 8, 2024 08:19 ET

  • Dogwood Therapeutics | 8-K: Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

    Nov 7, 2024 07:18 ET

  • Virios Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 9, 2024 10:17 ET

  • Virios Therapeutics | 8-K: Virios Therapeutics Announces Second Quarter 2024 Financial Results

    Aug 8, 2024 09:34 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    YETI Holdings
    YETI
    +3.75%
    New Fortress Energy
    NFE
    +1.00%
    Dorian LPG
    LPG
    +0.74%
    Precision Drilling
    PDS
    +0.01%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    0.00%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 14, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data